Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Kenjiro Jimbo"'
Autor:
Shohei Shikata, Takeshi Murata, Masayuki Yoshida, Hiromi Hashiguchi, Yukiko Yoshii, Ayumi Ogawa, Chikashi Watase, Sho Shiino, Hirokazu Sugino, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Adjuvant therapy for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-positive, early breast cancer (EBC) remains challenging. The prognostic significance of HER2-low positivity in
Externí odkaz:
https://doaj.org/article/fb74a75d0068451ba262689765aa4798
Autor:
Haruhi Maseki, Kenjiro Jimbo, Chikashi Watase, Takeshi Murata, Sho Shiino, Shin Takayama, Nami Yamamoto, Kaishi Satomi, Akiko Maeshima, Masayuki Yoshida, Akihiko Suto
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 9, Pp 3700-3704 (2023)
Background/Objective: The occurrence of iatrogenic tumor cell seeding (seeding) in needle tract scars formed by core needle biopsy (CNB) or vacuum-assisted biopsy (VAB) is well known. Some risk factors for seeding have been reported, but the clinicop
Externí odkaz:
https://doaj.org/article/0c293de1f59a4974a726cfbfe97cc135
Autor:
Takeshi Murata, Chikashi Watase, Sho Shiino, Arisa Kurita, Ayumi Ogawa, Kenjiro Jimbo, Eriko Iwamoto, Masayuki Yoshida, Shin Takayama, Akihiko Suto
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background There are currently no scoring-type predictive models using only easily available pre- and intraoperative data developed for assessment of the risk of advanced axillary lymph node metastasis (ALNM) in patients with breast cancer w
Externí odkaz:
https://doaj.org/article/655f5125b02645369f9b14f517b3cc7f
Autor:
Ai Hironaka-Mitsuhashi, Shin Takayama, Kenjiro Jimbo, Akihiko Suto, Akihiko Shimomura, Takahiro Ochiya
Publikováno v:
Archives of Breast Cancer, Vol 9, Iss 1 (2022)
Background: Recurrence of breast cancer remains a critical problem. Therefore, it is imperative to identify biomarkers that accurately reflect disease state and develop novel drug therapies that are effective even after recurrence. MicroRNAs (miRNAs)
Externí odkaz:
https://doaj.org/article/d6063d6c41c04093b1da0848ec6ad7bd
Autor:
Kaishi Satomi, Kenjiro Jimbo, Chikako Shimizu, Chikako Sekine, Eriko Iwamoto, Takeshi Murata, Sho Shiino, Shin Takayama, Akiko Maeshima, Takayuki Kinoshita, Kenji Tamura, Masayuki Yoshida
Publikováno v:
Human Pathology: Case Reports, Vol 21, Iss , Pp 200394- (2020)
Metaplastic carcinoma (MC) is a highly malignant tumor that is mainly classified as a triple-negative subtype exhibiting basal markers on immunohistochemical testing. Immunohistochemical findings of S-100 and SOX10 are useful and valuable in the diff
Externí odkaz:
https://doaj.org/article/0be7ae074d8744d29b6ea24522a37af4
Autor:
Takeshi Murata, Masayuki Yoshida, Sho Shiino, Ayumi Ogawa, Chikashi Watase, Kaishi Satomi, Kenjiro Jimbo, Akiko Maeshima, Eriko Iwamoto, Shin Takayama, Akihiko Suto
Publikováno v:
Breast Cancer Research and Treatment. 199:57-66
Purpose The impact of progesterone receptor (PR) status on the prognosis of breast cancer after isolated locoregional recurrence (ILRR) remains unclear. This study evaluated the impact of clinicopathologic factors, including PR status of ILRR, on dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::152b1ce974b0ba9d8a3311ce280deaf0
https://doi.org/10.1007/s10549-023-06901-7
https://doi.org/10.1007/s10549-023-06901-7
Autor:
Eisuke Ochi, Katsunori Tsuji, Tomomi Narisawa, Yoichi Shimizu, Aya Kuchiba, Akihiko Suto, Kenjiro Jimbo, Shin Takayama, Taro Ueno, Naomi Sakurai, Yutaka J Matsuoka
Publikováno v:
Cancer Research. 82:P4-11
Background: A strategy for maintaining and/or improving cardiorespiratory fitness (CRF) in the growing population of cancer survivors is of major clinical importance in the COVID-19 era. With the aim of increasing CRF, recent studies have focused on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5274b1e29211ff43a664fb86c5550d63
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-11
https://doi.org/10.1158/1538-7445.sabcs21-p4-11-11
Autor:
Tomoharu Sugie, Yasuo Ohashi, Takanori Ishida, Hironori Haga, Akira Shimizu, Masahiro Takada, Nobuaki Sato, Shigehira Saji, Hiroshi Ishiguro, Kenjiro Aogi, Hiroji Iwata, Takayuki Kinoshita, Masahiro Kitada, Toshiaki Saeki, Yuichiro Kai, Yasuyuki Sato, Kenjiro Jimbo, Norikazu Masuda, Shigeru Imoto, Yoshinori Ito, Takafumi Ikeda, Hirofumi Mukai, Masakazu Toi, Takayuki Ueno, Shinji Ohno
Publikováno v:
The Lancet Oncology. 22:74-84
Oral fluoropyrimidines, such as S-1, have been shown to have a role in controlling disease progression in metastatic breast cancer. We examined adjuvant treatment with S-1 in patients with oestrogen receptor (ER)-positive and HER2-negative primary br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bad68821e2ea2c358d254d013f8d4351
https://doi.org/10.1016/s1470-2045(20)30534-9
https://doi.org/10.1016/s1470-2045(20)30534-9
Autor:
Kan Yonemori, Jumpei Kashima, Tetsuo Ushiku, Kenjiro Jimbo, Masayuki Yoshida, Akihiko Yoshida, Koji Izutsu
Publikováno v:
American Journal of Surgical Pathology. 45:347-355
Originally described as a systemic self-limiting disease in infancy, the spectrum of ALK-positive histiocytosis has recently been broadened to include localized diseases in older children and young adults. Despite different manifestations, these tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40cef540393e347168839ee7b8472e37
https://doi.org/10.1097/pas.0000000000001567
https://doi.org/10.1097/pas.0000000000001567
Autor:
Toshiaki Saeki, Hironori Haga, Takafumi Ikeda, Hiroshi Ishiguro, Norikazu Masuda, Takanori Ishida, Yuichiro Kai, Takayuki Kinoshita, Nobuaki Sato, Masakazu Toi, Masahiro Takada, Yoshinori Ito, Hiroji Iwata, Shinji Ohno, Tomoharu Sugie, Yasuyuki Sato, Kenjiro Jimbo, Akira Shimizu, Shigehira Saji, Takayuki Ueno, Yasuo Ohashi, Kenjiro Aogi, Masahiro Kitada, Hirofumi Mukai, Shigeru Imoto
Publikováno v:
Cancer Research. 80:GS1-09
BACKGROUND: Although long-term prognostic outcomes of primary breast cancer (PBC) patients have been improved remarkably in recent years, the disease recurrence remains a serious problem. We have previously investigated a role for oral fluoropyrimidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::294d93d9936824a570fcd8f07ee078ea
https://doi.org/10.1158/1538-7445.sabcs19-gs1-09
https://doi.org/10.1158/1538-7445.sabcs19-gs1-09